Shree Ganesh Remedies Ltd banner

Intrinsic Value

The intrinsic value of Shree Ganesh Remedies Ltd (540737) under the Base Case is 499.82 INR per share. Compared with the current market price of 654 INR, the stock appears Overvalued by 24% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

SGRL Intrinsic Value
₹499.82
Overvaluation 24%
Intrinsic Value
Price ₹654
Alert me when SGRL is below its intrinsic value
Today ₹399.86 · 38.9% below the current price

SGRL is more expensive than usual. It was this expensive or more expensive on just 14% of days in the past 5 years.

Alternatives to SGRL

Fundamental Analysis

What Shree Ganesh Remedies Does

Pharmaceuticals Health Care

Shree Ganesh Remedies Ltd makes chemical ingredients used by drug makers and other industrial customers. Its business is centered on manufacturing pharmaceutical intermediates and related specialty chemicals, which are the building blocks that go into finished medicines. The company sells these products to pharmaceutical companies, chemical distributors, and other buyers that need consistent, high-purity raw materials.

Headquarters
India IN
IPO date
Oct 13, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Shree Ganesh Remedies Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one SGRL stock?

The intrinsic value for Shree Ganesh Remedies Ltd (540737) under the Base Case is 499.82 INR.

Is SGRL stock undervalued or overvalued?

Compared with the current market price of 654 INR, the stock appears Overvalued by 24% .

Back to Top